Aceragen’s abstract entitled “ASAH1-related disorders: Expanding phenotypic spectrum requires updated thinking on diagnostic testing” has been selected for a poster presentation at the European Human Genetics Conference ESHG 2022, Vienna, Austria June 11-14, 2022. ESHG Conference 2022 The poster will be presented on June 13th from 15:45-16:45 CEST by Katie Crosby, Assoc. Director of Patient
The abstract entitled “Enhanced in vitro activity of sodium fusidate against bacterial biothreat panels at low pH” has been accepted for a poster presentation at the ASM Microbe, the American Society for Microbiology Annual Conference, Washington, DC June 9-13, 2022. The poster (#2340) will be presented on June 10 at 10:30am to 11:30am and 4:00pm
The abstract entitled “Polyarticular arthritis and adult-onset osteolysis caused by mutations in the ASAH1 gene: Farber disease clinical presentations in the context of a first-ever natural history study” has been selected for a poster presentation at the EULAR Annual European Congress of Rheumatology, Copenhagen, Denmark June 1-4, 2022. The poster (#POS0222) will be presented on June 3rd 12:58 -13:06
